[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"iol-implantation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:iol-implantation":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100620957","myopia-progression-control-using-atropine-005-after-pediatric-cataract-surgery-and-intraocular-lens-implantation-surgery-100620957",false,"NCT07364370","Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery","Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery: A Randomized Clinical Trial","Inclusion criteria:\n\n1. Children after IOL implantation (primary or secondary)\n2. Age 1-7 years\n\nExclusion criteria:\n\n1. Eyes with post-operative media opacity hindering adequate assessment of refraction\n2. Eyes with complicated surgeries (e.g. vitreous loss, dropped lens matter requiring PPV, retinal detachment, etc)\n3. Retinal pathologies\n4. Glaucoma (congenital or secondary to surgery)\n5. Anterior or posterior segment anomalies","ALL","1 Year","7 Years",{"count":20,"type":21},50,"ESTIMATED","INTERVENTIONAL",[24],"NA","Myopic shift remains a debilitating and unpredictable adverse event following pediatric cataract surgery. While research exploring peripheral myopic defocus for post-cataract surgery myopia prevention shows promising results, the use of multifocal intra-ocular lenses (IOLs) cannot be used liberally in countries with high disease burden and challenged economies due to high price and decreased availability. To date there are no studies evaluating the use of topical atropine for the management of myopic shift following pediatric cataract surgery.\n\nThe investigators aim to explore the use of 0.05% topical atropine in the prevention and management of myopic shift following pediatric cataract surgery.",[27,28,29],"Pediatric Cataract","IOL Implantation","Myopia Progression",[31,32,33,34],"pediatric cataract","iol","iol implantation","myopia","NOT_YET_RECRUITING","2026-01-15",{"date":38,"type":39},"2026-01-23","ACTUAL",{"date":41,"type":21},"2026-02",{"date":43,"type":21},"2027-12",{"name":45,"class":46},"Cairo University","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":4,"studyType":22,"phases":60,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":81,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":47},"100596918","head-to-head-comparison-of-five-enhanced-depth-of-focus-iols-and-one-monofocal-iol-100596918","NCT07051720","Head-to-Head Comparison of Five Enhanced Depth of Focus IOLs and One Monofocal IOL","Visual Performance, Patient Satisfaction, and Quality of Vision Outcomes in Presbyopia-Correcting IOLs: A Prospective Clinical Study","AKA-Reports","Inclusion Criteria:\n\n* Bilateral implantation of the same intraocular lens (IOL) model\n* Expected postoperative best-corrected distance visual acuity (BCDVA) of 0.8 (decimal) or better\n* Regular corneal astigmatism less than 1 diopter\n\nExclusion Criteria:\n\n* Endothelial cell density \\\u003C 2,000 cells\u002Fmm²\n* Required IOL power for emmetropia falls outside the available range of +10.0 D to +30.0 D\n* Pupillary abnormalities\n* Intraocular inflammation\n* Recent ocular trauma or ocular surgery that is unresolved\u002Funstable, or which may impair visual outcomes or increase patient risk\n* History of corneal refractive surgery (e.g., LASIK, LASEK, PRK)\n* Irregular astigmatism, as well as corneal abnormalities or opacities\n* Conditions associated with an increased risk of zonular rupture, including capsular or zonular anomalies that may lead to IOL decentration or tilt, such as pseudoexfoliation syndrome, trauma, Marfan syndrome, among others\n* Systemic or ocular diseases, or medications, that may impair vision, increase surgical risk, or confound study outcomes\n* Clinically significant dry eye disease affecting visual function\n* Anticipated need for retinal laser treatment or any other ocular surgical intervention during the study period\n* Pregnancy, planned pregnancy, breastfeeding, or any condition associated with hormonal fluctuations that may induce refractive changes\n* Continuous contact lens wear within the past 4 weeks\n* Inability to understand and\u002For complete study questionnaires\n* Advanced glaucoma with visual field defects\n* Age-related macular degeneration (exudative or geographic form)","22 Years","85 Years",{"count":59,"type":21},180,[24],"Study Goal\n\nThe goal of this clinical trial is to compare how well four different types of artificial lenses (called intraocular lenses or IOLs) help people see after cataract surgery. The main questions it aims to answer are:\n\nWhich lens gives the best vision at different distances (far, middle, and close)? How satisfied are patients with their vision after surgery? How often do patients still need glasses after surgery?\n\nWho Can Participate Adults aged 22 to 85 years who need cataract surgery in both eyes and meet specific health requirements.\n\nStudy Design\n\nResearchers compared six different lens types:\n\nTECNIS Eyhance - designed to improve middle-distance vision AcrySof IQ Vivity - extends the range of clear vision LuxSmart - uses special optics for better depth of focus Rayner EMV - uses gradual light-bending technology for smooth vision transition Eycryl SERT - modifies light focus to extend clear vision range CT ASPHINA 409M - standard single-focus lens (comparison group)\n\nParticipants chose their preferred lens type after learning about each option's benefits and limitations.\n\nWhat Participants Do? Participants will:\n\nHave cataract surgery on both eyes (1-2 weeks apart) Complete vision tests at multiple distances Take contrast sensitivity tests under different lighting conditions Fill out questionnaires about vision quality and daily activities Attend follow-up visits at 1 day, 1 week, 1 month, and 3 months\n\nThis study helps patients and doctors make informed decisions about which type of artificial lens might work best for individual needs and lifestyle.",[63,28,64,65],"Cataract and IOL Surgery","Presbyopia Correction","Extended Depth of Focus",[67,68,69,70,71,72,73,74,75,76,77,78,79,80],"Cataract surgery","Extended depth-of-focus","EDOF","Intraocular lens","Presbyopia correction","Spectacle independence","Visual outcomes","Patient satisfaction","TECNIS Eyhance","AcrySof IQ Vivity","LuxSmart","CT Asphina","RayOne EMV","Eyecryl SERT","RECRUITING","2025-07-01",{"date":84,"type":39},"2025-07-04",{"date":86,"type":39},"2022-04-12",{"date":88,"type":21},"2026-01",{"name":90,"class":46},"Augenklinik Ahaus G + H GmbH & Co. KG"]